New high-throughput platform accelerates antibody testing for disease research
University of Illinois researchers have developed oPool+ display, a breakthrough method that enables researchers to construct and test hundreds of antibodies in parallel rather than individually. The platform dramatically reduces costs and time for antibody discovery across multiple diseases, with the aim of transforming therapeutic development for cancer, infectious diseases, and autoimmune conditions.













